{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:41:12Z","timestamp":1791996072231,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,18]],"date-time":"2024-03-18T00:00:00Z","timestamp":1710720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019779","name":"Qatar National Library","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ajo.2024.03.019","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T13:12:58Z","timestamp":1710853978000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational &amp; Experimental Studies"],"prefix":"10.1016","volume":"264","author":[{"given":"Muhammad","family":"Talha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Haris Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7103-9364","authenticated-orcid":false,"given":"Eeshal","family":"Fatima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arsalan","family":"Nadeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4845-4119","authenticated-orcid":false,"given":"Abdulqadir J.","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ajo.2024.03.019_bib0001","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/ACI.0b013e32833df9f4","article-title":"Pathogenic role of Demodex mites in blepharitis","volume":"10","author":"Liu","year":"2010","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0002","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/opo.12691","article-title":"Ocular Demodex: a systematic review of the clinical literature","volume":"40","author":"Zhang","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.019_bib0003","first-page":"1236","article-title":"Prevalence of Demodex colonization in patients presenting to an outpatient clinic","volume":"62","author":"Teo","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.ajo.2024.03.019_bib0004","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2147\/OPTH.S354692","article-title":"The prevalence of Demodex blepharitis in US eye care clinic patients as determined by collarettes: a pathognomonic sign","volume":"16","author":"Trattler","year":"2022","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/0974-9233.142268","article-title":"Blepharitis: always remember demodex","volume":"21","author":"Bhandari","year":"2014","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.019_bib0006","first-page":"361","article-title":"Demodex folliculorum blepharitis","volume":"65","author":"Coston","year":"1967","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"11","key":"10.1016\/j.ajo.2024.03.019_bib0007","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/bjo.2005.072363","article-title":"In vitro and in vivo killing of ocular Demodex by tea tree oil","volume":"89","author":"Gao","year":"2005","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0008","doi-asserted-by":"crossref","first-page":"589","DOI":"10.18240\/ijo.2021.04.17","article-title":"The association between Demodex infestation and ocular surface manifestations in meibomian gland dysfunction","volume":"11","author":"Zhang","year":"2018","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.019_bib0009","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.2147\/OPTH.S374530","article-title":"Psychosocial impact of Demodex blepharitis","volume":"16","author":"O'Dell","year":"2022","journal-title":"Clin Ophthalmol Auckl NZ"},{"issue":"2","key":"10.1016\/j.ajo.2024.03.019_bib0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5114\/aoms.2016.60663","article-title":"The impact of age, sex, blepharitis, rosacea and rheumatoid arthritis on Demodex mite infection","volume":"14","author":"S\u0119dzikowska","year":"2018","journal-title":"Arch Med Sci AMS"},{"key":"10.1016\/j.ajo.2024.03.019_bib0011","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2019.03.007","article-title":"Demodex mite infestation and its associations with tear film and ocular surface parameters in patients with ocular discomfort","volume":"204","author":"Rabensteiner","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.019_bib0012","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ICO.0000000000002911","article-title":"Update on the management of Demodex blepharitis","volume":"41","author":"Shah","year":"2022","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0013","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jtos.2019.06.004","article-title":"Efficacy of treatments for Demodex blepharitis: a systematic review and meta-analysis","volume":"17","author":"Navel","year":"2019","journal-title":"Ocul Surf"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.019_bib0014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2021.0011","article-title":"Collarette elimination and Demodex mite eradication with topical lotilaner ophthalmic solution, 0.25%","volume":"37","author":"Gonzalez-Salinas","year":"2021","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.ajo.2024.03.019_bib0015","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3862684","article-title":"Safety and efficacy of topical lotilaner ophthalmic solution 0.25% for the treatment of Demodex blepharitis: a pilot study","volume":"2021","author":"Gonzalez-Salinas","year":"2021","journal-title":"J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2021.101492","article-title":"Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: a randomized, controlled, double-masked clinical trial","volume":"45","author":"Gonzalez-Salinas","year":"2022","journal-title":"Contact Lens Anterior Eye"},{"issue":"0","key":"10.1016\/j.ajo.2024.03.019_bib0017","first-page":"1","article-title":"Treatment of Demodex blepharitis: a prospective, randomized, controlled, double-masked clinical trial comparing topical lotilaner ophthalmic solution, 0.25% eyedrops to vehicle","volume":"0","author":"Yeu","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0018","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/ICO.0000000000003097","article-title":"Lotilaner ophthalmic solution, 0.25%, for the treatment of Demodex blepharitis: results of a prospective, randomized, vehicle-controlled, double-masked, pivotal trial (saturn-1)","volume":"42","author":"Yeu","year":"2023","journal-title":"Cornea"},{"issue":"10","key":"10.1016\/j.ajo.2024.03.019_bib0019","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.ophtha.2023.05.030","article-title":"Lotilaner ophthalmic solution 0.25% for Demodex blepharitis: randomized, vehicle-controlled, multicenter, phase 3 trial (saturn-2)","volume":"130","author":"Gaddie","year":"2023","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.019_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.bbrc.2009.11.131","article-title":"The antiparasitic isoxazoline A1443 is a potent blocker of insect ligand-gated chloride channels","volume":"391","author":"Ozoe","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.ajo.2024.03.019_bib0021","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s13071-017-2475-z","article-title":"The intravenous and oral pharmacokinetics of lotilaner in dogs","volume":"10","author":"Toutain","year":"2017","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.ajo.2024.03.019_bib0022","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2024.03.019_bib0023","unstructured":"NHLBI, NIH Study Quality Assessment Tools. Accessed October 23, 2023. https:\/\/www.nhlbi.nih.gov\/health-topics\/study-quality-assessment-tools"},{"key":"10.1016\/j.ajo.2024.03.019_bib0024","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"issue":"7651","key":"10.1016\/j.ajo.2024.03.019_bib0025","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"7650","key":"10.1016\/j.ajo.2024.03.019_bib0026","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.ajo.2024.03.019_bib0027","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1038\/s41433-023-02500-4","article-title":"Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH)","volume":"37","author":"Ayres","year":"2023","journal-title":"Eye"},{"issue":"3","key":"10.1016\/j.ajo.2024.03.019_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.clae.2020.04.011","article-title":"Topical ivermectin-metronidazole gel therapy in the treatment of blepharitis caused by Demodex spp.: a randomized clinical trial","volume":"44","author":"\u00c1vila","year":"2021","journal-title":"Contact Lens Anterior Eye"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0029","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/jcm12041649","article-title":"Demodicosis in Different age groups and alternative treatment options\u2014a review","volume":"12","author":"Chudzicka-Struga\u0142a","year":"2023","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.ajo.2024.03.019_bib0030","article-title":"Tea tree oil for Demodex blepharitis","author":"Savla","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajo.2024.03.019_bib0031","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/OPTO.S111130","article-title":"Contact lens wear and dry eyes: challenges and solutions","volume":"9","author":"Markoulli","year":"2017","journal-title":"Clin Optom (Auckl)"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0032","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/ICO.0000000000002802","article-title":"Efficacy of topical ivermectin 1% in the treatment of Demodex blepharitis","volume":"41","author":"Choi","year":"2022","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0033","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00417-023-06281-0","article-title":"Topical ivermectin ointment treatment of Demodex blepharitis: a 6-year retrospective study","volume":"262","author":"Valvecchia","year":"2024","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2024.03.019_bib0034","article-title":"Treatment of ocular Demodex infestation with topical ivermectin cream","volume":"26","author":"Helm","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"8702","key":"10.1016\/j.ajo.2024.03.019_bib0035","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/0140-6736(90)91253-7","article-title":"Safety of and compliance with community-based ivermectin therapy","volume":"335","author":"Pacque","year":"1990","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ajo.2024.03.019_bib0036","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1017\/S003118202000150X","article-title":"Comparison of the efficacy of tea tree (Melaleuca alternifolia) oil with other current pharmacological management in human demodicosis: a systematic review","volume":"147","author":"Lam","year":"2020","journal-title":"Parasitology"},{"issue":"4","key":"10.1016\/j.ajo.2024.03.019_bib0037","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/bjd.13408","article-title":"Superiority of ivermectin 1% cream over metronidazole 0.75% cream in treating inflammatory lesions of rosacea: a randomized, investigator-blinded trial","volume":"172","author":"Taieb","year":"2015","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.ajo.2024.03.019_bib0038","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ICO.0000000000002911","article-title":"Update on the management of Demodex blepharitis","volume":"41","author":"Shah","year":"2022","journal-title":"Cornea"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424001211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T16:00:46Z","timestamp":1737388846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424001211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":38,"alternative-id":["S0002939424001211"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.019","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.03.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}